LAMP1 and neoplasm: In vitro studies demonstrated optimal cell viability, increased expression of surface CD107a or lysosome-associated membrane protein 1 (LAMP-1) on CAR-NK cells co-cultured with CDH17-positive cancer cells, and enhanced anti-tumor responses.